Emergency Medicine Respiratory General Medicine Strong — NICE CG191 endorsed
CURB-65 Score for Pneumonia
Estimates 30-day mortality risk and guides admission decisions in community-acquired pneumonia
References
- Lim WS, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003;58(5):377–82.
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Doxapram hydrochloride · Respiratory stimulant
- Cefuroxime · Second-Generation Cephalosporin — Respiratory / Surgical Prophylaxis
- Clarithromycin · Macrolide Antibiotic — Respiratory / H. pylori / MAC
- Lefamulin · Pleuromutilin Antibiotic (Community-Acquired Pneumonia)
- Respiratory syncytial virus (RSV) vaccine · RSV pre-fusion F protein vaccine
- Ceftriaxone (Paediatric) · Third-Generation Cephalosporin — Meningitis / Sepsis / Community-Acquired Pneumonia
Pathways
Same specialty
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines
- Syncope Assessment · ESC 2018 Syncope Guidelines; NICE NG109
Decision support only — verify against MDCalc, NICE, or your local guideline before clinical use.